Beuselinck, Benoit <br/><br/>
Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Mar 2015 
 - 1329-39 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-14-1128  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Renal Cell--classification<br/>Disease-Free Survival<br/>Drug Resistance, Neoplasm<br/>Female<br/>Gene Expression Profiling<br/>Humans<br/>Indoles--therapeutic use<br/>Kidney Neoplasms--classification<br/>Male<br/>Mutation--genetics<br/>Pyrroles--therapeutic use<br/>Sunitinib<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor Receptor-2--antagonists & inhibitors